Skip to content
Some content is members-only. Sign in to access.

KAPUALabs

Meta in AI Era: Bull Case on Trust, Bear Case on Returns

By KAPUALabs
/
Meta in AI Era: Bull Case on Trust, Bear Case on Returns

Semaglutide vs Tirzepatide: A Formulation-Based Clinical Assessment

By KAPUALabs
/
Semaglutide vs Tirzepatide: A Formulation-Based Clinical Assessment

Meta's Optical Relay Strategy: UALink and Smart Glasses

By KAPUALabs
/
Meta's Optical Relay Strategy: UALink and Smart Glasses

The AI Capex Conundrum: How Meta and Peers Are Redefining Free Cash Flow in 2026

By KAPUALabs
/
The AI Capex Conundrum: How Meta and Peers Are Redefining Free Cash Flow in 2026

Meta's Pivot Beyond Advertising: A Comprehensive Analysis

By KAPUALabs
/
Meta's Pivot Beyond Advertising: A Comprehensive Analysis

Lilly's Obesity Franchise: Bullish on Pipeline, Bearish on Legal Risks

By KAPUALabs
/
Lilly's Obesity Franchise: Bullish on Pipeline, Bearish on Legal Risks

The 'Gulag' Within: How Meta's AI Ambitions Are Crushing Employee Morale

By KAPUALabs
/
The 'Gulag' Within: How Meta's AI Ambitions Are Crushing Employee Morale

Meta’s AI Transformation: A Deep Dive into Strategy and Risk

By KAPUALabs
/
Meta’s AI Transformation: A Deep Dive into Strategy and Risk

Meta's Regulatory Crossroads: A Comprehensive Analysis

By KAPUALabs
/
Meta's Regulatory Crossroads: A Comprehensive Analysis

Meta's AI Pivot: Capital Reallocation and Strategic Overhaul

By KAPUALabs
/
Meta's AI Pivot: Capital Reallocation and Strategic Overhaul